Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Mid-range Performer
1205.0000 -31.30 (-2.53%)
NSE Jul 31, 2025 09:54 AM
Volume: 100.1K
 

1205.00
-2.53%
Prabhudas Lilladhar
We reduce earnings estimate of JUBILANT by 23%17.5%11.6% for FY21/22/23E due to weak and inconsistent performance of its Pharmaceutical segment (65% revenue and 78% EBITDA contribution in FY20) whose key contributors Radio pharma and Allergy are currently witnessing lower volumes caused by pandemic in US. Radiopharma being a hospital driven...
Jubilant Pharmova Ltd. is trading above all available SMAs
More from Jubilant Pharmova Ltd.
Recommended